Home > Riviste > Minerva Ginecologica > Fascicoli precedenti > Minerva Ginecologica 2019 April;71(2) > Minerva Ginecologica 2019 April;71(2):125-32

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW  UPDATES ON MATERNAL FETAL MEDICINE 

Minerva Ginecologica 2019 April;71(2):125-32

DOI: 10.23736/S0026-4784.18.04341-1

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Pearls in clinical obstetrics: challenges in anticoagulation in pregnancy

Micaela DELLA TORRE , Monique B. SUTHERLAND, Laura M. DIGIOVANNI

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL, USA



Women are at increased risk for venous thromboembolism (VTE) during both pregnancy and in the post-partum period. We have conducted a comprehensive literature review of the use of anticoagulation in pregnancy for pregnant women at increased risk for VTE. Multiple factors, including physiologic and pharmacokinetic changes make the treatment and prevention of VTE complicated in pregnancy. Adequate treatment and prevention of VTE in pregnancy is critically important, yet good quality medical studies continue to be lacking. There is a growing amount of data for the use of low molecular weight heparin (LMWH) in pregnant women and this remains the treatment of choice in most indications. For both prophylactic and therapeutic treatments, when LMWHs are chosen, monitoring of antifactor Xa level, although controversial, is advised. Women with prosthetic valve who become pregnant face challenges in regard of type of anticoagulation, dosing and monitoring during pregnancy. Delivery options and peripartum care should be defined with a multidisciplinary approach and taking patient’s preference and autonomy in consideration. More high-quality research on this topic is needed to guide the clinical care of this unique population.


KEY WORDS: Anticoagulants - Pregnancy - Heparin, low-molecular-weight - Thromboembolism

inizio pagina